| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 1,326,070 | 1,189,880 | ||
| Investments | 720,000 | 480,000 | ||
| Accounts receivable, net of allowances | 764,364 | 714,004 | ||
| Inventories | 483,111 | 504,989 | ||
| Prepaid expenses | 146,892 | 164,000 | ||
| Other current assets | 315,441 | 297,560 | ||
| Total current assets | 3,755,878 | 3,350,433 | ||
| Property, plant and equipment, net | 188,913 | 184,975 | ||
| Operating lease assets | 61,204 | 63,082 | ||
| Intangible assets, net | 4,565,737 | 4,768,987 | ||
| Goodwill | 1,827,483 | 1,843,974 | ||
| Deferred tax assets, net | 846,168 | 602,903 | ||
| Deferred financing costs | 8,034 | 8,516 | ||
| Other non-current assets | 103,068 | 121,271 | ||
| Total assets | 11,356,485 | 10,944,141 | ||
| Accounts payable | 152,227 | 89,366 | ||
| Accrued liabilities | 1,001,556 | 874,811 | ||
| Current portion of long-term debt | 1,029,179 | 1,028,478 | ||
| Income taxes payable | 91,140 | 78,550 | ||
| Total current liabilities | 2,274,102 | 2,071,205 | ||
| Long-term debt, less current portion | 4,331,982 | 4,335,616 | ||
| Operating lease liabilities, less current portion | 53,426 | 55,107 | ||
| Deferred tax liabilities, net | 629,033 | 682,123 | ||
| Other non-current liabilities | 108,912 | 93,731 | ||
| Ordinary shares | 6 | 6 | ||
| Non-voting euro deferred shares | 55 | 55 | ||
| Capital redemption reserve | 473 | 473 | ||
| Additional paid-in capital | 4,085,669 | 4,000,280 | ||
| Accumulated other comprehensive loss | -569,898 | -485,768 | ||
| Retained earnings | 442,725 | 191,313 | ||
| Total shareholders equity | 3,959,030 | 3,706,359 | ||
| Total liabilities and shareholders equity | 11,356,485 | 10,944,141 | ||
Jazz Pharmaceuticals plc (JAZZ)
Jazz Pharmaceuticals plc (JAZZ)